Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Lindsay B KilburnDong Anh K Khoung-QuangJordan R HansfordDaniel LandiJasper van der LugtSarah E S LearyPablo Hernáiz DrieverSimon BaileySébastien PerreaultGeoffrey McCowageAngela J WaandersDavid S ZieglerOlaf WittPatricia A BaxterHyoung Jin KangTimothy E HassallJung Woo HanDarren R HargraveAndrea T FlynnMichal Yalon OrenHelen ToledanoValérie LaroucheCassie N KlineMohamed S AbdelbakiNada JabadoNicholas G GottardoNicolas U GerberNicholas S WhippleDevorah SegalSusan N ChiLiat OrenEnrica E K TanSabine MuellerIzzy CornelioLisa McLeodXin ZhaoAshley WalterDaniel Da CostaPeter ManleySamuel C BlackmanRoger J PackerKarsten NysomPublished in: Nature medicine (2024)